BridgeBio

📍 Palo Alto, United States🗓 Founded 2014👥 448 employees💰 Last funded Mar 2016
Biotechnology Research🌐 bridgebio.com
Website LinkedIn
BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BridgeBio?
BridgeBio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did BridgeBio last raise funding?
The most recent investment in BridgeBio recorded on gritt.io was in March 2016.
When was BridgeBio founded?
BridgeBio was founded in 2014.
What industry is BridgeBio in?
BridgeBio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BridgeBio based?
BridgeBio is headquartered in Palo Alto, United States.